Recent advances in mammalian protein production

FEBS Letters

Volumn 588, Issue 2, 2014, Pages 253-260

  Bandaranayake, Ashok D ^a   Almo, Steven C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Clonal selection; Mammalian expression; Protein production; Therapeutics

Indexed keywords

LENTIVIRUS VECTOR; RECOMBINANT PROTEIN;

CELL CLONING; CELL DENSITY; CELL GROWTH; CELL STRAIN HEK293; CHO CELL; DNA INTEGRATION; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; DRUG SELECTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; GENE AMPLIFICATION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; GLYCOSYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; SAFETY; TRANSIENT TRANSFECTION; VIRAL GENE DELIVERY SYSTEM;

MAMMALIA;

CLONAL SELECTION; MAMMALIAN EXPRESSION; PROTEIN PRODUCTION; THERAPEUTICS;

ANIMALS; CELL LINE; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; HUMANS; MAMMALS; RECOMBINANT PROTEINS;

EID: 84892367415     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.11.035     Document Type: Review

References (100)

1. J. Zhu Mammalian cell protein expression for biopharmaceutical production Biotechnol. Adv. 30 2012 1158 1170
2. S.C. Almo, S.J. Garforth, B.S. Hillerich, J.D. Love, R.D. Seidel, and S.K. Burley Protein production from the structural genomics perspective: achievements and future needs Curr. Opin. Struct. Biol. 2013 1 10
3. P. Savitsky, J. Bray, C.D.O. Cooper, B.D. Marsden, P. Mahajan, N.A. Burgess-Brown, and O. Gileadi High-throughput production of human proteins for crystallization: the SGC experience J. Struct. Biol. 172 2010 3 13
4. P.-H. Chen, X. Chen, Z. Lin, D. Fang, and X. He The structural basis of R-spondin recognition by LGR5 and RNF43 Genes Dev. 2013 1345 1350
5. M. Butler, and A. Meneses-Acosta Recent advances in technology supporting biopharmaceutical production from mammalian cells Appl. Microbiol. Biotechnol. 96 2012 885 894
6. S.R. Aggarwal What's fueling the biotech engine-2011 to 2012 Nat. Biotechnol. 30 2012 1191 1197
7. J.R. Birch, and Y. Onakunle Biopharmaceutical proteins: opportunities and challenges Methods Mol. Biol. 308 2005 1 16
8. L. Chu, and D.K. Robinson Industrial choices for protein production by large-scale cell culture Curr. Opin. Biotechnol. 2001 180 187
9. T. Puck, S. Cieciura, and A. Robinson Genetics of somatic mammalian cells III. Long-term cultivation of euploid cells from human and animal subjects J. Exp. Med. 108 1958 945 956
10. I. Deschênes, C.D. Finkle, and P.D. Winocour Effective use of BCH-2763, a new potent injectable direct thrombin inhibitor, in combination with tissue plasminogen activator (tPA) in a rat arterial thrombolysis model Thromb. Haemost. 80 1998 186 191
11. V. Jadhav, M. Hackl, A. Druz, S. Shridhar, C.-Y. Chung, K.M. Heffner, D.P. Kreil, M. Betenbaugh, J. Shiloach, N. Barron, J. Grillari, and N. Borth CHO microRNA engineering is growing up: recent successes and future challenges Biotechnol. Adv. 31 2013 1501 1513
12. K. Jayapal, and K. Wlaschin Recombinant protein therapeutics from CHO cells-20 years and counting Chem. Eng. Prog. 103 2007 40 47
13. F.M. Wurm Production of recombinant protein therapeutics in cultivated mammalian cells Nat. Biotechnol. 22 2004 1393 1398
14. R. Jefferis Glycosylation as a strategy to improve antibody-based therapeutics Nat. Rev. Drug Discovery 8 2009 226 234
15. A. Beck, and E. Wagner-Rousset Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins Curr. Pharm. Biotechnol. 9 2008 482 501
16. A.R. Costa, M.E. Rodrigues, M. Henriques, R. Oliveira, and J. Azeredo Glycosylation: impact, control and improvement during therapeutic protein production Crit. Rev. Biotechnol. 8551 2013 1 19
17. C.J. Bosques, B.E. Collins, J.W. Meador, H. Sarvaiya, J.L. Murphy, G. Dellorusso, D.A. Bulik, I.-H. Hsu, N. Washburn, S.F. Sipsey, J.R. Myette, R. Raman, Z. Shriver, R. Sasisekharan, and G. Venkataraman Chinese hamster ovary cells can produce galactose-α-1,3-galactose antigens on proteins Nat. Biotechnol. 28 2010 1153 1156
18. D.F. Arnold, and S.A. Misbah Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose N. Engl. J. Med. 358 2008 2735 author reply 2735-6
19. L.A. Chasin, and G. Urlaub Chromosome-wide event accompanies the expression of recessive mutations in tetraploid cells Science 187 1975 1091 1093
20. A.E. Simon, M.W. Taylor, W.E. Bradley, and L.H. Thompson Model involving gene inactivation in the generation of autosomal recessive mutants in mammalian cells in culture Mol. Cell. Biol. 2 1982 1126 1133
21. G. Urlaub, and L.A. Chasin Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity Proc. Natl. Acad. Sci. U.S.A. 77 1980 4216 4220
22. K.F. Wlaschin, P.M. Nissom, M. de L. Gatti, P.F. Ong, S. Arleen, K.S. Tan, A. Rink, B. Cham, K. Wong, M. Yap, and W.-S. Hu EST sequencing for gene discovery in Chinese hamster ovary cells Biotechnol. Bioeng. 91 2005 592 606
23. F.L. Graham, J. Smiley, W.C. Russell, and R. Nairn Characteristics of a human cell line transformed by DNA from human adenovirus type 5 J. Gen. Virol. 36 1977 59 74
24. F.L. Graham, and A.J. van der Eb Transformation of rat cells by DNA of human adenovirus 5 Virology 54 1973 536 539
25. F.L. Graham, and A.J. van der Eb A new technique for the assay of infectivity of human adenovirus 5 DNA Virology 52 1973 456 467
26. F.L. Graham Growth of 293 cells in suspension culture J. Gen. Virol. 68 Pt 3 1987 937 940
27. A. Garnier, J. Côté, I. Nadeau, A. Kamen, and B. Massie Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells Cytotechnology 15 1994 145 155
28. R.B. DuBridge, P. Tang, H.C. Hsia, P.M. Leong, J.H. Miller, and M.P. Calos Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system Mol. Cell. Biol. 7 1987 379 387
29. Y. Durocher, S. Perret, and A. Kamen High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells Nucleic Acids Res. 30 2002 e9
30. G. Walsh Post-translational modifications of protein biopharmaceuticals Drug Discovery Today 15 2010 773 780
31. G. Backliwal, M. Hildinger, S. Chenuet, S. Wulhfard, M. De Jesus, and F.M. Wurm Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions Nucleic Acids Res. 36 2008 e96
32. M.S. Cho, H. Yee, and S. Chan Establishment of a human somatic hybrid cell line for recombinant protein production J. Biomed. Sci. 9 2002 631 638
33. B. Mei, Y. Chen, J. Chen, C.Q. Pan, and J.E. Murphy Expression of human coagulation factor VIII in a human hybrid cell line, HKB11 Mol. Biotechnol. 34 2006 165 178
34. F. Fallaux, and A. Bout New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses Hum. Gene Ther. 9 1998 1909 1917
35. D. Jones, N. Kroos, R. Anema, B. van Montfort, A. Vooys, S. van der Kraats, E. van der Helm, S. Smits, J. Schouten, K. Brouwer, F. Lagerwerf, P. van Berkel, D.-J. Opstelten, T. Logtenberg, and A. Bout High-level expression of recombinant IgG in the human cell line per.c6 Biotechnol. Prog. 19 2003 163 168
36. G. Schiedner, S. Hertel, and S. Kochanek Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production Hum. Gene Ther. 11 2000 2105 2116
37. S. Fischer, N. Charara, A. Gerber, J. Wölfel, G. Schiedner, B. Voedisch, and S. Geisse Transient recombinant protein expression in a human amniocyte cell line: the CAP-T® cell system Biotechnol. Bioeng. 109 2012 2250 2261
38. S. Geisse Reflections on more than 10 years of TGE approaches Protein Expr. Purif. 64 2009 99 107
39. L. Baldi, D.L. Hacker, M. Adam, and F.M. Wurm Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives Biotechnol. Lett. 29 2007 677 684
40. N. Muller, P. Girard, D.L. Hacker, M. Jordan, and F.M. Wurm Orbital shaker technology for the cultivation of mammalian cells in suspension Biotechnol. Bioeng. 89 2005 400 406
41. X. Zhang, M. Stettler, O. Reif, A. Kocourek, M. Dejesus, D.L. Hacker, and F.M. Wurm Shaken helical track bioreactors: providing oxygen to high-density cultures of mammalian cells at volumes up to 1000 L by surface aeration with air New Biotechnol. 25 2008 68 75
42. S. Geisse, and M. Henke Large-scale transient transfection of mammalian cells: a newly emerging attractive option for recombinant protein production J. Struct. Funct. Genomics 6 2005 165 170
43. G. Schmid, E.J. Schlaeger, and B. Wipf Non-GMP plasmid production for transient transfection in bioreactors Cytotechnology 35 2001 157 164
44. A. Rozkov, B. Larsson, S. Gillström, R. Björnestedt, and S.R. Schmidt Large-scale production of endotoxin-free plasmids for transient expression in mammalian cell culture Biotechnol. Bioeng. 99 2008 557 566
45. R. Haldankar, D. Li, Z. Saremi, C. Baikalov, and R. Deshpande Serum-free suspension large-scale transient transfection of CHO cells in WAVE bioreactors Mol. Biotechnol. 34 2006 191 199
46. S. Geisse, M. Jordan, and F.M. Wurm Large-scale transient expression of therapeutic proteins in mammalian cells Methods Mol. Biol. 308 2005 87 98
47. C. Liu, B. Dalby, W. Chen, J.M. Kilzer, and H.C. Chiou Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells Mol. Biotechnol. 39 2008 141 153
48. Y. Rajendra, D. Kiseljak, L. Baldi, D.L. Hacker, and F.M. Wurm A simple high-yielding process for transient gene expression in CHO cells J. Biotechnol. 153 2011 22 26
49. G. Backliwal, M. Hildinger, and V. Hasija High-density transfection with HEK-293 cells allows doubling of transient titers and removes need for a priori DNA complex formation with PEI Biotechnology 99 2008 721 727
50. B. Figueroa, T.M. Sauerwald, A.J. Mastrangelo, J.M. Hardwick, and M.J. Betenbaugh Comparison of Bcl-2 to a Bcl-2 deletion mutant for mammalian cells exposed to culture insults Biotechnol. Bioeng. 73 2001 211 222
51. B.T. Tey, R.P. Singh, L. Piredda, M. Piacentini, and M. Al-Rubeai Influence of bcl-2 on cell death during the cultivation of a Chinese hamster ovary cell line expressing a chimeric antibody Biotechnol. Bioeng. 68 2000 31 43
52. N.S. Kim, and G.M. Lee Response of recombinant Chinese hamster ovary cells to hyperosmotic pressure: effect of Bcl-2 overexpression J. Biotechnol. 95 2002 237 248
53. B.S. Majors, M.J. Betenbaugh, N.E. Pederson, and G.G. Chiang Enhancement of transient gene expression and culture viability using Chinese hamster ovary cells overexpressing Bcl-x(L) Biotechnol. Bioeng. 101 2008 567 578
54. S.K. Lee, and G.M. Lee Development of apoptosis-resistant dihydrofolate reductase-deficient Chinese hamster ovary cell line Biotechnol. Bioeng. 82 2003 872 876
55. A.S. Tait, C.J. Brown, D.J. Galbraith, M.J. Hines, M. Hoare, J.R. Birch, and D.C. James Transient production of recombinant proteins by Chinese hamster ovary cells using polyethyleneimine/DNA complexes in combination with microtubule disrupting anti-mitotic agents Biotechnol. Bioeng. 88 2004 707 721
56. S. Geisse Transient expression technologies: past, present, and future Methods Mol. Biol. (Clifton, NJ) 899 2012
57. M. Wirth, J. Bode, G. Zettlmeissl, and H. Hauser Isolation of overproducing recombinant mammalian cell lines by a fast and simple selection procedure Gene 73 1988 419 426
58. S. Turan, M. Galla, E. Ernst, J. Qiao, C. Voelkel, B. Schiedlmeier, C. Zehe, and J. Bode Recombinase-mediated cassette exchange (RMCE): traditional concepts and current challenges J. Mol. Biol. 407 2011 193 221
59. S. Turan, J. Kuehle, A. Schambach, C. Baum, and J. Bode Multiplexing RMCE: versatile extensions of the Flp-recombinase-mediated cassette-exchange technology J. Mol. Biol. 402 2010 52 69
60. D.A. Sorrell, C.J. Robinson, J.-A. Smith, and A.F. Kolb Recombinase mediated cassette exchange into genomic targets using an adenovirus vector Nucleic Acids Res. 38 2010 e123
61. R. Torres, A. García, M. Payá, and J.C. Ramirez Non-integrative lentivirus drives high-frequency cre-mediated cassette exchange in human cells PLoS ONE 6 2011 e19794
62. V. Agrawal Strategies for rapid production of therapeutic proteins in mammalian cells Bioprocess Int. 10 2012
63. M. Wiznerowicz, and D. Trono Harnessing HIV for therapy, basic research and biotechnology Trends Biotechnol. 23 2005 42 47
64. A.D. Bandaranayake, C. Correnti, B.Y. Ryu, M. Brault, R.K. Strong, and D.J. Rawlings Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors Nucleic Acids Res. 39 2011 e143
65. A. Oberbek, M. Matasci, D.L. Hacker, and F.M. Wurm Generation of stable, high-producing CHO cell lines by lentiviral vector-mediated gene transfer in serum-free suspension culture Biotechnol. Bioeng. 41 2010
66. T. Lai, Y. Yang, and S. Ng Advances in mammalian cell line development technologies for recombinant protein production Pharmaceuticals 6 2013 579 603
67. B. Zhu, D. Benjamin, Y. Zheng, H. Angliker, S. Thiry, M. Siegmann, and J.P. Jost Overexpression of 5-methylcytosine DNA glycosylase in human embryonic kidney cells EcR293 demethylates the promoter of a hormone-regulated reporter gene Proc. Natl. Acad. Sci. U.S.A. 98 2001 5031 5036
68. J.P. Jost, E.J. Oakeley, B. Zhu, D. Benjamin, S. Thiry, M. Siegmann, and Y.C. Jost 5-Methylcytosine DNA glycosylase participates in the genome-wide loss of DNA methylation occurring during mouse myoblast differentiation Nucleic Acids Res. 29 2001 4452 4461
69. J.P. Bidwell, K. Torrungruang, M. Alvarez, S.J. Rhodes, R. Shah, D.R. Jones, K. Charoonpatrapong, J.M. Hock, and A.J. Watt Involvement of the nuclear matrix in the control of skeletal genes: the NMP1 (YY1), NMP2 (Cbfa1), and NMP4 (Nmp4/CIZ) transcription factors Crit. Rev. Eukaryot. Gene Expr. 11 2001 279 297
70. A.C. Bell, A.G. West, and G. Felsenfeld The protein CTCF is required for the enhancer blocking activity of vertebrate insulators Cell 98 1999 387 396
71. P.-A. Girod, D.-Q. Nguyen, D. Calabrese, S. Puttini, M. Grandjean, D. Martinet, A. Regamey, D. Saugy, J.S. Beckmann, P. Bucher, and N. Mermod Genome-wide prediction of matrix attachment regions that increase gene expression in mammalian cells Nat. Methods 4 2007 747 753
72. P.-A. Girod, M. Zahn-Zabal, and N. Mermod Use of the chicken lysozyme 5′ matrix attachment region to generate high producer CHO cell lines Biotechnol. Bioeng. 91 2005 1 11
73. J. Do Kim, Y. Yoon, H.-Y. Hwang, J.S. Park, S. Yu, J. Lee, K. Baek, and J. Yoon Efficient selection of stable chinese hamster ovary (CHO) cell lines for expression of recombinant proteins by using human interferon beta SAR element Biotechnol. Prog. 21 2005 933 937
74. J.-M. Kim, J.-S. Kim, D.-H. Park, H.S. Kang, J. Yoon, K. Baek, and Y. Yoon Improved recombinant gene expression in CHO cells using matrix attachment regions J. Biotechnol. 107 2004 95 105
75. M. Zahn-Zabal, M. Kobr, P.A. Girod, M. Imhof, P. Chatellard, M. de Jesus, F. Wurm, and N. Mermod Development of stable cell lines for production or regulated expression using matrix attachment regions J. Biotechnol. 87 2001 29 42
76. M. Antoniou, L. Harland, T. Mustoe, S. Williams, J. Holdstock, E. Yague, T. Mulcahy, M. Griffiths, S. Edwards, P. Ioannou, A. Mountain, and R. Crombie Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing Genomics 82 2003 269 279
77. S. Williams, T. Mustoe, T. Mulcahy, M. Griffiths, D. Simpson, M. Antoniou, A. Irvine, A. Mountain, and R. Crombie CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells BMC Biotechnol. 5 2005 17
78. F. Zhang, S.I. Thornhill, S.J. Howe, M. Ulaganathan, A. Schambach, J. Sinclair, C. Kinnon, H.B. Gaspar, M. Antoniou, and A.J. Thrasher Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells Blood 110 2007 1448 1457
79. F. Zhang, A.R. Frost, M.P. Blundell, O. Bales, M.N. Antoniou, and A.J. Thrasher A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors Mol. Ther. 18 2010 1640 1649
80. J. Ye, K. Alvin, H. Latif, A. Hsu, V. Parikh, T. Whitmer, M. Tellers, M.C. de la Cruz Edmonds, J. Ly, P. Salmon, and J.F. Markusen Rapid protein production using CHO stable transfection pools Biotechnol. Prog. 26 2010 1431 1437
81. K. Sautter, and B. Enenkel Selection of high-producing CHO cells using NPT selection marker with reduced enzyme activity Biotechnol. Bioeng. 89 2005 530 538
82. S.C.L. Ho, M. Bardor, H. Feng, Mariati, Y.W. Tong, Z. Song, M.G.S. Yap, and Y. Yang IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines J. Biotechnol. 157 2012 130 139
83. H. Niwa, K. Yamamura, and J. Miyazaki Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 108 1991 193 199
84. A.D. Westwood, D.A. Rowe, and H.R.G. Clarke Improved recombinant protein yield using a codon deoptimized DHFR selectable marker in a CHEF1 expression plasmid Biotechnol. Prog. 26 2010 1558 1566
85. R. Zhang, and W. Shen Monoclonal antibody expression in Mammalian cells Antib. Eng. 907 2012 341 358
86. G. Urlaub, E. Käs, A.M. Carothers, and L.A. Chasin Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells Cell 33 1983 405 412
87. R.J. Kaufman, and P.A. Sharp Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary dna gene J. Mol. Biol. 159 1982 601 621
88. S.K. Ng, D.I.C. Wang, and M.G.S. Yap Application of destabilizing sequences on selection marker for improved recombinant protein productivity in CHO-DG44 Metab. Eng. 9 2007 304 316
89. S.K. Ng, T.R.M. Tan, Y. Wang, D. Ng, L.-T. Goh, M. Bardor, V.V.T. Wong, and K.P. Lam Production of functional soluble Dectin-1 glycoprotein using an IRES-linked destabilized-dihydrofolate reductase expression vector PLoS ONE 7 2012 e52785
90. L.M. Barnes, C.M. Bentley, and A.J. Dickson Advances in animal cell recombinant protein production: GS-NS0 expression system Cytotechnology 32 2000 109 123
91. H. Pu, L.M. Cashion, P.J. Kretschmer, and Z. Liu Rapid establishment of high-producing cell lines using dicistronic vectors with glutamine synthetase as the selection marker Mol. Biotechnol. 10 1998 17 25
92. R.E. Kingston, R.J. Kaufman, C.R. Bebbington, and M.R. Rolfe Amplification using CHO cell expression vectors Curr. Protoc. Mol. Biol. 2002 Chapter 16, Unit 16.23
93. L. Fan, I. Kadura, L.E. Krebs, C.C. Hatfield, M.M. Shaw, and C.C. Frye Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells Biotechnol. Bioeng. 109 2012 1007 1015
94. A. Orfao, and A. Ruiz-Arguelles General concepts about cell sorting techniques Clin. Biochem. 29 1996 5 9
95. S.M. Young, C. Bologa, E.R. Prossnitz, T.I. Oprea, L.A. Sklar, and B.S. Edwards High-throughput screening with HyperCyt flow cytometry to detect small molecule formylpeptide receptor ligands J. Biomol. Screen. 10 2005 374 382
96. S.F. Ibrahim, and G. van den Engh High-speed cell sorting: fundamentals and recent advances Curr. Opin. Biotechnol. 14 2003 5 12
97. M. Song, K. Raphaelli, M.L. Jones, K. Aliabadi-Zadeh, K.M. Leung, D. Crowley, B. Hughes, S. Mahler, P.P. Gray, E.P. Huang, and D.Y. Chin Clonal selection of high producing, stably transfected HEK293 cell lines utilizing modified, high-throughput FACS screening J. Chem. Technol. Biotechnol. 86 2011 935 941
98. J. Pichler, F. Hesse, M. Wieser, R. Kunert, S.S. Galosy, J.E. Mott, and N. Borth A study on the temperature dependency and time course of the cold capture antibody secretion assay J. Biotechnol. 141 2009 80 83
99. T. Yoshikawa, F. Nakanishi, Y. Ogura, D. Oi, T. Omasa, Y. Katakura, M. Kishimoto, and K.I. Suga Flow cytometry: an improved method for the selection of highly productive gene-amplified CHO cells using flow cytometry Biotechnol. Bioeng. 74 2001 435 442
100. Y. Durocher, and M. Butler Expression systems for therapeutic glycoprotein production Curr. Opin. Biotechnol. 20 2009 700 707